BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26038110)

  • 1. Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs.
    Keller B; García-Sevilla JA
    J Psychopharmacol; 2015 Sep; 29(9):996-1012. PubMed ID: 26038110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of imidazoline receptor ligands on basal and kainic acid-induced neurotoxic signalling in mice.
    Keller B; García-Sevilla JA
    J Psychopharmacol; 2016 Sep; 30(9):875-86. PubMed ID: 27302941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of IRAS/nischarin and other potential I
    Keller B; García-Sevilla JA
    J Affect Disord; 2017 Jan; 208():646-652. PubMed ID: 27836117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists.
    Ivanov TR; Feng Y; Wang H; Regunathan S; Reis DJ; Chikkala DN; Gupta P; Jones JC; Piletz JE
    J Psychiatr Res; 1998; 32(2):65-79. PubMed ID: 9694002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of I
    Keller B; García-Sevilla JA
    Neurochem Int; 2017 Sep; 108():169-176. PubMed ID: 28342965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.
    Escribá PV; Alemany R; Sastre M; Olmos G; Ozaita A; García-Sevilla JA
    Br J Pharmacol; 1996 Aug; 118(8):2029-36. PubMed ID: 8864539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.
    Olmos G; Alemany R; Boronat MA; García-Sevilla JA
    Ann N Y Acad Sci; 1999 Jun; 881():144-60. PubMed ID: 10415910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.
    Escribá PV; Ozaita A; García-Sevilla JA
    Ann N Y Acad Sci; 1999 Jun; 881():8-25. PubMed ID: 10415892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of I1 and I2 imidazoline receptors in striatum membranes from different species.
    Vauquelin G; De Backer JP; Ladure P; Flamez A
    Ann N Y Acad Sci; 1999 Jun; 881():135-43. PubMed ID: 10415909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazoline Receptor System: The Past, the Present, and the Future.
    Bousquet P; Hudson A; García-Sevilla JA; Li JX
    Pharmacol Rev; 2020 Jan; 72(1):50-79. PubMed ID: 31819014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of platelet α2-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses.
    Hikasa Y; Masuda K; Asakura Y; Yamashita Y; Sato C; Kamio M; Miura A; Taniguchi T; Minamizuru N
    Eur J Pharmacol; 2013 Nov; 720(1-3):363-75. PubMed ID: 24120658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing the effect of I
    Fehér Á; Tóth VE; Al-Khrasani M; Balogh M; Lázár B; Helyes Z; Gyires K; Zádori ZS
    Inflammopharmacology; 2017 Feb; 25(1):107-118. PubMed ID: 27873165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent increases of immunoreactive imidazoline receptors in the human brain: possible association of a 29/30 kDa protein with the I2-imidazoline receptor identified by [3H]idazoxan.
    García-Sevilla JA; Sastre M; Escribá PV
    Neurosci Lett; 1995 Jan; 184(2):133-6. PubMed ID: 7724047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I
    Abás S; Erdozain AM; Keller B; Rodríguez-Arévalo S; Callado LF; García-Sevilla JA; Escolano C
    ACS Chem Neurosci; 2017 Apr; 8(4):737-742. PubMed ID: 28029766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
    Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands.
    Anastassiadou M; Danoun S; Crane L; Baziard-Mouysset G; Payard M; Caignard DH; Rettori MC; Renard P
    Bioorg Med Chem; 2001 Mar; 9(3):585-92. PubMed ID: 11310592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I1-imidazoline receptors: an update.
    Bousquet P; Dontenwill M; Greney H; Feldman J
    J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.